Your browser doesn't support javascript.
loading
LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
Dräger, Julia; Simon-Keller, Katja; Pukrop, Tobias; Klemm, Florian; Wilting, Jörg; Sticht, Carsten; Dittmann, Kai; Schulz, Matthias; Leuschner, Ivo; Marx, Alexander; Hahn, Heidi.
Afiliação
  • Dräger J; Department of Human Genetics, University Medical Center, Göttingen 37073, Germany.
  • Simon-Keller K; Institute of Pathology, University Medical Center Mannheim, Mannheim 68167, Germany.
  • Pukrop T; Clinic for Internal Medicine III, Hematology and Medical Oncology, University Regensburg, Regensburg 93053, Germany.
  • Klemm F; Department of Hematology/Medical Oncology, University Medical Center Göttingen, Göttingen 37099, Germany.
  • Wilting J; Department of Hematology/Medical Oncology, University Medical Center Göttingen, Göttingen 37099, Germany.
  • Sticht C; Institute of Anatomy and Cell Biology, University Medical Center Göttingen, Göttingen 37075, Germany.
  • Dittmann K; Center of Medical Research, Bioinformatic and Statistic, Medical Faculty Mannheim, Mannheim 68167, Germany.
  • Schulz M; Institute for Cellular and Molecular Immunology, University Medical Center Göttingen, Göttingen 37073, Germany.
  • Leuschner I; Department of Hematology/Medical Oncology, University Medical Center Göttingen, Göttingen 37099, Germany.
  • Marx A; Kiel Paediatric Tumor Registry, Department of Paediatric Pathology, University Hospital Schleswig-Holstein, Kiel 24105, Germany.
  • Hahn H; Institute of Pathology, University Medical Center Mannheim, Mannheim 68167, Germany.
Oncotarget ; 8(2): 3259-3273, 2017 Jan 10.
Article em En | MEDLINE | ID: mdl-27965462

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Fator 1 de Ligação ao Facilitador Linfoide Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Fator 1 de Ligação ao Facilitador Linfoide Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha